動物用皮膚科薬の世界市場：市場規模・シェア・動向分析 (適応症別・種類別・動物の種類別・投与経路別・流通チャネル別・地域別)、セグメント別予測 (2025年～2030年)

動物用皮膚科薬市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物用皮膚科薬市場規模は2030年までに295億1,000万米ドルに達し、2025年から2030年までのCAGRは9.60%を記録すると予測されています。

この市場を牽引するのは、ペットへの支出の増加、ペットの人間化、堅調な研究開発パイプライン、新製品の発売、皮膚疾患の流行、主要企業の取り組みなどです。例えば、2023年6月、Zoetis社はApoquel Chewable (犬のアレルギー性かゆみと炎症を抑える国内初で唯一のチュアブル医薬品) のFDA認可を取得しました。これにより、同社のポートフォリオが拡大し、成長目標が達成されました。

2020年から2022年にかけてのCOVID-19パンデミックとマクロ経済の逆風は、市場にプラスとマイナスの両方の影響を与えました。これには、経営上の課題、サプライチェーンの混乱、獣医療へのアクセスの制限、ペット飼育の急増、遠隔医療の採用、ペット保険の普及拡大などが含まれます。例えば、ヴィミアンは、四半期間の出荷量の変動により、皮膚科・専門医療分野の2022年第1四半期の成長が鈍化したと報告しています。2022年第3四半期には、同社は皮膚科と専門医療分野で力強い成長を報告しました。一方、Zoetis社は、2021年第2四半期、第3四半期、第4四半期に、皮膚科製品を含むインライン・ポートフォリオからそれぞれ14%、3%、9%の数量成長を示しました。しかし、2022年には、ゾエティスの皮膚科製品ポートフォリオの販売数量は毎四半期1～2%の伸びを示しました。

動物用皮膚科の領域における継続的な研究開発努力により、より効果的で使い勝手の良い製剤が開発されています。このような製剤はしばしば投与が容易で、ペットに迅速な救済をもたらし、服薬コンプライアンスを確保することができます。主要な市場参入企業によるイニシアチブの高まりは、研究開発パイプラインを促進し、市場における新製品の発売を促進すると予想されます。例えば2023年5月、Dechra Pharmaceuticals PLCはスコットランドのILC Therapeuticsと提携し、犬のアトピー性皮膚炎の治療薬として後者のCaniferon製品を研究開発しました。これにより、同社の製品パイプラインがさらに充実しました。

動物用皮膚科薬市場：分析概要

• 適応症別では、寄生虫感染症分野が市場を独占し、主要企業の戦略的イニシアチブの増加により、2024年には42.49%以上の最大収益シェアを占めました。
• 例えば、Virbac社は2021年3月にElanco社から多数の初期段階の寄生虫駆除薬の権利を購入し、医薬品ラインナップを拡大しました。
• アレルギー性感染症分野は、予測期間中に9.9%を超える最速のCAGRが見込まれます。
• 2024年の市場規模は処方薬セグメントが圧倒的でしたが、2025年から2030年にかけてはOTCセグメントが最も速いCAGR約9.7%で成長すると予測されます。
• コンパニオンアニマルは、ペット飼育の増加、社会的認識、質の高い動物ケアへの需要により、2024年の市場を独占しました。
• 2024年には局所薬セグメントが市場を独占しており、予測期間中に有利なCAGRを記録すると予想されます。
• 流通チャネル別では、病院薬局が2024年の収益シェア62.36%で市場を独占しました。
• 北米は2024年に市場の38.29%以上の最高収益シェアを占めました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 動物用皮膚科薬市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
  • 市場機会の分析
  • 市場の課題の分析
• 動物用皮膚科薬市場：分析ツール
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • 価格分析
  • 臨床試験分析
  • 主要国別の動物の推定個体数 (2018～2024年)
  • COVID-19の影響分析

第4章 動物用皮膚科薬市場：適応症別の推定・動向分析

• セグメントダッシュボード
• 動物用皮膚科薬市場：適応症変動分析と市場シェア、2024年と2030年
• 寄生虫感染症
• アレルギー感染症
• その他

第5章 動物用皮膚科薬市場：種類別の推定・動向分析

• セグメントダッシュボード
• 動物用皮膚科薬市場：変動分析と市場シェア、種類別 (2024年・2030年)
• 処方薬
• OTC (市販薬)

第6章 動物用皮膚科薬市場：動物の種類別の推定・動向分析

• セグメントダッシュボード
• 動物用皮膚科薬市場：変動分析と市場シェア、動物の種類別 (2024年・2030年)
• コンパニオンアニマル
• 家畜

第7章 動物用皮膚科薬市場：投与経路別の推定・動向分析

• セグメントダッシュボード
• 動物用皮膚科薬市場：変動分析と市場シェア、投与経路別 (2024年・2030年)
• 局所薬
• 経口薬
• 注入薬

第8章 動物用皮膚科薬市場：流通チャネル別の展望・推定・予測

• セグメントダッシュボード
• 動物用皮膚科薬市場：変動分析と市場シェア、流通チャネル別 (2024年・2030年)
• 病院薬局
• 小売薬局
• eコマース

第9章 動物用皮膚科薬市場：地域別の展望・推定・予測

• 地域別の展望
• 動物用皮膚科薬市場：変動分析と市場シェア、地域別 (2024年・2030年)
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 市場参入企業の分類
• 企業の市況分析/ヒープマップ分析
• 企業プロファイル
  • Zoetis Inc.
  • Boehringer Ingelheim International Gmbh
  • Merck &Co., Inc.
  • Elanco
  • Ceva
  • Virbac SA
  • Bimeda, Corporate
  • Vetoquinol SA
  • Biogenesis Bago
  • Vivaldis
• 戦略マッピング
  • 企業合併・買収 (M&A)
  • パートナーシップとコラボレーション
  • 拡大
  • 製品発売
  • 製品承認
  • その他
• その他の企業の一覧

第11章 重要なポイント

List of Tables

• Table 1 List of secondary sources
• Table 2 Global Veterinary Dermatology Drugs market, by region, 2018 - 2030 (USD Million)
• Table 3 Global Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 4 Global Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 5 Global Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 6 Global Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 7 Global Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 8 North America Veterinary Dermatology Drugs market, by country, 2018 - 2030 (USD Million)
• Table 9 North America Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 10 North America Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 11 North America Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 12 North America Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 13 North America Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 14 U.S. Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 15 U.S. Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 16 U.S. Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 17 U.S. Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 18 U.S. Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19 Canada Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 20 Canada Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 21 Canada Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 22 Canada Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 23 Canada Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 24 Europe Veterinary Dermatology Drugs market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 26 Europe Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 27 Europe Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 28 Europe Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 29 Europe Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 30 UK Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 31 UK Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 32 UK Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 33 UK Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 34 UK Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 35 Germany Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 36 Germany Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 37 Germany Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 38 Germany Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 39 Germany Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 40 France Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 41 France Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 42 France Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 43 France Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 44 France Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 45 Italy Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 46 Italy Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 47 Italy Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 48 Italy Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 49 Italy Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 50 Spain Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 51 Spain Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 52 Spain Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 53 Spain Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 54 Spain Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55 Denmark Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 56 Denmark Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 57 Denmark Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 58 Denmark Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 59 Denmark Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 60 Sweden Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 61 Sweden Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 62 Sweden Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 63 Sweden Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 64 Sweden Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 65 Norway Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 66 Norway Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 67 Norway Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 68 Norway Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 69 Norway Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific Veterinary Dermatology Drugs market, by country, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 76 Japan Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 77 Japan Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 78 Japan Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 79 Japan Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 80 Japan Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 81 China Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 82 China Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 83 China Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 84 China Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 85 China Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 86 India Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 87 India Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 88 India Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 89 India Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 90 India Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 91 South Korea Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 92 South Korea Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 93 South Korea Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 94 South Korea Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 95 South Korea Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 96 Australia Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 97 Australia Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 98 Australia Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 99 Australia Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 100 Australia Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 101 Thailand Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 102 Thailand Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 103 Thailand Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 104 Thailand Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 105 Thailand Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 106 Latin America Veterinary Dermatology Drugs market, by country, 2018 - 2030 (USD Million)
• Table 107 Latin America Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 108 Latin America Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 109 Latin America Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 110 Latin America Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 111 Latin America Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 112 Brazil Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 113 Brazil Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 114 Brazil Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 115 Brazil Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 116 Brazil Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 117 Mexico Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 118 Mexico Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 119 Mexico Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 120 Mexico Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 121 Mexico Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 122 Argentina Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 123 Argentina Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 124 Argentina Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 125 Argentina Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 126 Argentina Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 127 MEA Veterinary Dermatology Drugs market, by country, 2018 - 2030 (USD Million)
• Table 128 MEA Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 129 MEA Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 130 MEA Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 131 MEA Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 132 MEA Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 133 South Africa Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 134 South Africa Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 135 South Africa Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 136 South Africa Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 137 South Africa Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 143 UAE Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 144 UAE Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 145 UAE Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 146 UAE Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 147 UAE Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 148 Kuwait Veterinary Dermatology Drugs market, by indication, 2018 - 2030 (USD Million)
• Table 149 Kuwait Veterinary Dermatology Drugs market, by type, 2018 - 2030 (USD Million)
• Table 150 Kuwait Veterinary Dermatology Drugs market, by animal type, 2018 - 2030 (USD Million)
• Table 151 Kuwait Veterinary Dermatology Drugs market, by route of administration, 2018 - 2030 (USD Million)
• Table 152 Kuwait Veterinary Dermatology Drugs market, by distribution channel, 2018 - 2030 (USD Million)
• Table 153 Participant's overview
• Table 154 Financial performance
• Table 155 Indication/ Services benchmarking
• Table 156 Strategic Initiatives

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 QFD modelling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Commodity Flow Analysis
• Fig. 9 Veterinary Dermatology Drugs market revenue, 2018 - 2030 (USD Million)
• Fig. 10 Veterinary Dermatology Drugs Market Snapshot
• Fig. 11 Veterinary Dermatology Drugs market driver impact
• Fig. 12 Veterinary Dermatology Drugs market restraint impact
• Fig. 13 Porter's 5 Forces Analysis
• Fig. 14 PESTEL Analysis
• Fig. 15 Veterinary Dermatology Drugs market indication key takeaways (USD Million)
• Fig. 16 Veterinary Dermatology Drugs market: indication movement analysis
• Fig. 17 Global Parasitic Infections market, 2018 - 2030 (USD Million)
• Fig. 18 Global Allergic Infections market, 2018 - 2030 (USD Million)
• Fig. 19 Global Others market, 2018 - 2030 (USD Million)
• Fig. 20 Veterinary Dermatology Drugs type key takeaways (USD Million)
• Fig. 21 Veterinary Dermatology Drugs market: Type movement analysis
• Fig. 22 Global prescription market, 2018 - 2030 (USD Million)
• Fig. 23 Global OTC market, 2018 - 2030 (USD Million)
• Fig. 24 Veterinary Dermatology Drugs market animal type key takeaways (USD Million)
• Fig. 25 Veterinary Dermatology Drugs market: Animal type movement analysis
• Fig. 26 Global companion animals market, 2018 - 2030 (USD Million)
• Fig. 27 Companion animals dogs market, 2018 - 2030 (USD Million)
• Fig. 28 Companion animals cats market, 2018 - 2030 (USD Million)
• Fig. 29 Companion animals horses market, 2018 - 2030 (USD Million)
• Fig. 30 Companion animals others market, 2018 - 2030 (USD Million)
• Fig. 31 Global livestock animals market, 2018 - 2030 (USD Million)
• Fig. 32 Livestock animals cattle market, 2018 - 2030 (USD Million)
• Fig. 33 Livestock animals others market, 2018 - 2030 (USD Million)
• Fig. 34 Veterinary Dermatology Drugs market route of administration key takeaways (USD Million)
• Fig. 35 Veterinary Dermatology Drugs market: route of administration movement analysis
• Fig. 36 Global topical market, 2018 - 2030 (USD Million)
• Fig. 37 Global oral market, 2018 - 2030 (USD Million)
• Fig. 38 Global injectable market, 2018 - 2030 (USD Million)
• Fig. 39 Veterinary Dermatology Drugs market distribution channel key takeaways (USD Million)
• Fig. 40 Veterinary Dermatology Drugs market: distribution channel movement analysis
• Fig. 41 Global hospital pharmacies market, 2018 - 2030 (USD Million)
• Fig. 42 Global retail market, 2018 - 2030 (USD Million)
• Fig. 43 Global e-commerce market, 2018 - 2030 (USD Million)
• Fig. 44 Regional market place: Key takeaways
• Fig. 45 Regional Outlook, 2024 & 2030
• Fig. 46 North America Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 47 U.S. Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 48 Canada Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 49 Europe Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 50 UK Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 51 Germany Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 52 France Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 53 Italy Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 54 Spain Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 55 Denmark Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 56 Sweden Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 57 Norway Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 59 Japan Veterinary Dermatology Drugs Market, 2018 - 2030 (USD Million)
• Fig. 60 China Veterinary Dermatology Drugs Market, 2018 - 2030 (USD Million)
• Fig. 61 India Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 62 South Korea Veterinary Dermatology Drugs Market, 2018 - 2030 (USD Million)
• Fig. 63 Australia Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 64 Thailand Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 65 Latin America Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 66 Brazil Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 67 Mexico Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 68 Argentina Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 69 MEA Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 70 South Africa Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 71 Saudi Arabia Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 72 UAE Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 73 Kuwait Veterinary Dermatology Drugs market, 2018 - 2030 (USD Million)
• Fig. 74 Market participant categorization
• Fig. 75 Heat map analysis
• Fig. 76 Strategy Mappings

Veterinary Dermatology Drugs Market Growth & Trends:

The global veterinary dermatology drugs market size is expected to reach USD 29.51 billion by 2030, registering a CAGR of 9.60% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing pet expenditure, humanization of pets, robust R&D pipeline, launch of new products, the prevalence of dermatologic conditions, and initiatives by key companies. For example, in June 2023, Zoetis received FDA clearance for Apoquel Chewable- the country's first and only chewable pharmaceutical for controlling allergic itch and inflammation in dogs. This expanded the company's portfolio and supported its growth objectives.

The COVID-19 pandemic and macroeconomic headwinds from 2020 to 2022 had both positive and negative impacts on the market. This included operational challenges, supply chain disruption, limited access to veterinary care, spike in pet adoption, adoption of telemedicine, and increased penetration of pet insurance. Vimian for instance, reported dampened growth during Q1 2022 in its dermatology & specialty care segments due to volatility in shipments between quarters. By Q3 2022, the company reported robust growth in Dermatology & Specialty Care segments. Zoetis on the other hand witnessed volume growth of 14%, 3%, and 9% from in-line portfolio, including its dermatology products during Q2, Q3, and Q4 2021 respectively. In 2022, however, Zoetis reported 1-2% volume growth in its dermatology portfolio every quarter.

Ongoing research and development efforts in the field of veterinary dermatology have led to the creation of more effective and user-friendly drug formulations. These formulations are often easier to administer and can provide quicker relief for pets, ensuring medication compliance. Growing initiatives by key market players is expected to propel the R&D pipeline and promote the launch of new products in the market. In May 2023, Dechra Pharmaceuticals PLC for example, partnered with ILC Therapeutics in Scotland to research and develop the latter's Caniferon product for the treatment of atopic dermatitis in dogs. This added to the company's product pipeline.

Veterinary Dermatology Drugs Market Report Highlights:

• By indication, the parasitic infections segment dominated the market and held the largest revenue share of more than 42.49% in 2024 owing to increasing strategic initiatives by key companies
• For instance, Virbac expanded its medicinal product line by purchasing the rights to a number of early-stage parasiticides from Elanco in March 2021
• The allergic infections segment is anticipated to witness the fastest CAGR of over 9.9% during the forecast period
• The prescription segment dominated the market in 2024, whereas, the OTC segment is anticipated to grow at the fastest CAGR of about 9.7% from 2025 to 2030
• The companion animals dominated the market in 2024, due to the rise in pet ownership, public awareness, and demand for high-quality animal care
• The topical segment dominated the market in 2024 is expected to witness lucrative CAGR during the forecast period
• By distribution channel, hospital pharmacies dominated the market with a revenue share of 62.36% in 2024
• North America held the highest revenue share of over 38.29% of the market in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Dermatology Drugs Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Pet Ownership
    • 3.2.1.2. Growing Number Of Clinical Trials Related To Veterinary Dermatology Drugs
    • 3.2.1.3. Rising Incidence Rate Of Parasitic As Well As Other Skin Diseases In Animals
    • 3.2.1.4. Investments By Market Players
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack Of Awareness In Developing Regions
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Dermatology Drugs Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Clinical Trial Analysis
  • 3.3.5. Estimated Animal Population, by key countries, 2018 to 2024
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Veterinary Dermatology Drugs Market: Indication Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Dermatology Drugs Market: Indication Movement Analysis & Market Share, 2024 & 2030
• 4.3. Parasitic Infections
  • 4.3.1. Parasitic Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Allergic Infections
  • 4.4.1. Allergic Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Others
  • 4.5.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Dermatology Drugs Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Dermatology Drugs Market: Type Movement Analysis & Market Share, 2024 & 2030
• 5.3. Prescription
  • 5.3.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. OTC
  • 5.4.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Dermatology Drugs Market: Animal Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Dermatology Drugs Market: Animal Type Movement Analysis & Market Share, 2024 & 2030
• 6.3. Companion Animals
  • 6.3.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4.1. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Livestock Animals
  • 6.4.1. Livestock Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Dermatology Drugs Market: Route of Administration Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Dermatology Drugs Market: Route of Administration Movement Analysis & Market Share, 2024 & 2030
• 7.3. Topical
  • 7.3.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Oral
  • 7.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Injectable
  • 7.5.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Dermatology Drugs Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Veterinary Dermatology Drugs Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
• 8.3. Hospital Pharmacies
  • 8.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Retail
  • 8.4.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. E-Commerce
  • 8.5.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Dermatology Drugs Market: Regional Estimates & Trend Analysis

• 9.1. Regional Outlook
• 9.2. Veterinary Dermatology Drugs Market: Regional Movement Analysis & Market Share, 2024 & 2030
• 9.3. North America
  • 9.3.1. North America Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. U.S. Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Canada Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. UK Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Germany Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. France Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Italy Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Spain Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Denmark Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Sweden Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Norway Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Japan Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. China Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. India Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. South Korea Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Australia Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Thailand Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Brazil Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. Mexico
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Mexico Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. Argentina
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Argentina Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7. Middle East & Africa
  • 9.7.1. Middle East & Africa Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. South Africa Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Saudi Arabia Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. UAE Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Kuwait Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Company Market Position Analysis/ Heap Map Analysis
• 10.3. Company Profiles
  • 10.3.1. Zoetis Inc.
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Boehringer Ingelheim International Gmbh
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Merck & Co., Inc.
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Elanco
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Ceva
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. Virbac S.A.
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. Bimeda, Corporate
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Vetoquinol SA
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Biogenesis Bago
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Vivaldis
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Expansion
  • 10.4.4. Product launch
  • 10.4.5. Product Approval
  • 10.4.6. Others
• 10.5. List of Other Players

Chapter 11. Key Takeaways